DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory ...
Novel HLA Typing Assay: Available in an Early Access Program, this potentially disruptive technology offers same-day, long-read-based genotyping with rapid turnaround and flexible throughput, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback